Susquehanna International Group, LLP Kiniksa Pharmaceuticals, Ltd. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 07, 2024
BUY
$17.63 - $21.74 $1.31 Million - $1.62 Million
74,400 Added 155.97%
122,100 $2.41 Million
Q4 2023

Feb 14, 2024
BUY
$14.37 - $19.07 $196,869 - $261,259
13,700 Added 40.29%
47,700 $836,000
Q3 2023

Nov 14, 2023
BUY
$13.62 - $20.2 $309,174 - $458,540
22,700 Added 200.88%
34,000 $590,000
Q2 2023

Aug 11, 2023
BUY
$10.44 - $16.48 $117,972 - $186,224
11,300 New
11,300 $159,000
Q3 2022

Nov 14, 2022
SELL
$9.76 - $13.41 $63,440 - $87,165
-6,500 Reduced 18.52%
28,600 $367,000

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $690M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email